PharmaResearch reports third-quarter operating profit up 1.2%, revenue up 26.7%
PharmaResearch disclosed preliminary consolidated third-quarter operating profit of 62.6 billion won, up 1.2% from a year earlier. Revenue rose 26.7% to 171.5 billion won, while net income fell 40.5% to 30.2 billion won. Exports accounted for approximately 48% of quarterly revenue.